ADvance

The ADvance study is a Phase II study testing the safety, tolerability, and cognitive effects of a surgically implanted neurostimulation device.

Individuals 55-80 years of age with a diagnosis of mild Alzheimer’s disease may be eligible. The study includes one baseline visit, one surgical implant visit, one surgical follow-up visit, and 8 study visits.

Download a one-page overview of this study including contact information